Delivery Order SPE2DB24D9313-SPE2DB25FYBHL
- Not listed
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $19,405.50 to DMS Pharmaceutical Group Inc. for 200-unit vials of Botox, with an ultimate completion date of September 23, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The product will be delivered to Park Ridge, Illinois and will support pharmaceutical supply needs within the federal...
- The Defense Logistics Agency awarded a delivery order valued at $9,251.40 to DMS Pharmaceutical Group Inc. for BOTOX 100 unit vials on August 13, 2025, with an ultimate completion date of September 4, 2025. This firm fixed-price delivery order was issued without a set-aside designation and will be performed at the vendor's location in Park Ridge, Illinois. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, was selected as the awardee based on its established...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $46,148.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 100-unit vials of the drug Botox, with a completion date of July 12, 2024. This order is issued under DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which allows...
- The Defense Logistics Agency awarded a delivery order valued at $3,881.10 to DMS Pharmaceutical Group Inc. for 200-unit vials of Botox on August 25, 2025, with an ultimate completion date of September 16, 2025. This firm fixed-price delivery order was issued without a set-aside designation and is being performed in Park Ridge, Illinois, where the contractor is based. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, was selected to supply this specialized...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $5,537.76 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of Botox 100 unit vials to support the recurring medical supply needs of military health facilities. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $9,251.40 to DMS Pharmaceutical Group Inc. for the supply of Botox 100 unit vials. The contract was awarded on September 3, 2025, with an ultimate completion date of September 24, 2025, and will be performed in Park Ridge, Illinois. This delivery order was issued without a set-aside designation, allowing DMS Pharmaceutical Group to compete on an unrestricted basis despite its status as a woman-owned small...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $25,874.00 to DMS Pharmaceutical Group Inc. for the supply of 200-unit vials of Botox. The award was issued on September 8, 2025, with an ultimate completion date of September 29, 2025, and will be performed at the contractor's facility in Park Ridge, Illinois. This delivery order was issued without a set-aside designation, allowing the woman-owned small business to compete on an unrestricted basis in the...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $6,922.20 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The order is for the supply of 100-unit vials of Botox under the DLA's SPE2DB indefinite delivery contract (IDC), which has a ceiling value of up to $499,999,999 and runs through December 31, 2025. DMS Pharmaceutical Group is a key supplier of pharmaceuticals and medical supplies to the Department of...
- The Defense Logistics Agency awarded a $12,937.00 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Botox 200 unit vials. The award, made on September 10, 2025, with an ultimate completion date of October 1, 2025, was issued without set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA valued at...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $9,229.60 contract is for the supply of BOTOX 100 unit vials to support the recurring medical needs of military health facilities. This delivery order is part of a larger, single-award indefinite delivery contract (IDC) between the DLA and DMS Pharmaceutical Group valued at up to...
- SPE2DB24D9313Indefinite Delivery Contract
- SPE2DB24D9313-SPE2DB25FYBHLDelivery Order
The Defense Logistics Agency awarded a $9,702.75 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on September 10, 2025, for 200-unit vials of Botox, with an ultimate completion date of October 1, 2025. The award was issued without a set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its facilities in Park Ridge. This delivery order represents a relatively modest pharmaceutical procurement within the broader context of DLA's medical supply operations supporting Department of Defense healthcare facilities. This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 and valid through November 2026. The underlying IDC enables DLA to procure a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables necessary to support military health facilities worldwide. As a long-standing federal contractor registered in SAM.gov since 2001, DMS Pharmaceutical Group has demonstrated consistent capability in supplying specialty pharmaceutical products to the Department of Defense, positioning itself as a key participant in the federal pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.7k | 9/10/25 |